ORKA-002

· Oruka Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for ORKA-002, covering 2025-09-26 to 2026-04-22. Get the full timeline:

Most recent: Clinical Trial Update: Dose Ranging Study of ORKA-002 in Patients With Moderate-to-Severe Plaque Psoriasis [Phase 2]